Testbank for pharmacotherapeutics for advanced practice nurse
prescribers 6th edition
, Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition | Complete TestBank
Table of Contents
Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th
Edition
Unit I — The Foundation
Chapter Chapter Title
1 The Role of the Nurse Practitioner as Prescriber
2 Review of Basic Principles of Pharmacology
3 Rational Drug Selection
4 Legal and Professional Issues in Prescribing
5 Adverse Drug Reactions
6 An Introduction to Pharmacogenetics and Pharmacogenomics
7 Nutrition and Nutraceuticals
8 Herbal Therapies
9 Cannabis
10 Pharmacoeconomics
Unit II — Pharmacotherapeutics With Single Drugs
Chapter Chapter Title
11 Drugs Affecting the Autonomic Nervous System
12 Drugs Affecting the Central Nervous System
13 Drugs Affecting the Cardiovascular and Renal Systems
14 Drugs Affecting the Respiratory System
15 Drugs Affecting the Hematological System
16 Drugs Affecting the Immune System: Immunizations
17 Drugs Affecting the Immune System: Immunomodulators
18 Drugs Affecting the Gastrointestinal System
19 Pancreatic Hormones and Antidiabetic Drugs
20 Pituitary, Thyroid, and Adrenal Drugs
21 Drugs Affecting the Reproductive System
22 Drugs Affecting the Bones and Joints
23 Drugs Affecting the Integumentary System
24 Drugs Used to Treat Bacterial Infections
25 Drugs Used to Treat Viral, Fungal, and Protozoal Infections
26 Drugs Used to Treat Inflammatory Processes
27 Drugs Used to Treat Eye and Ear Disorders
Unit III — Pharmacotherapeutics With Multiple Drugs
Chapter Chapter Title
28 Anemia
29 Anxiety and Depression
30 Attention-Deficit/Hyperactivity Disorder
Page 2
, Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition | Complete TestBank
Chapter Chapter Title
31 Asthma and Allergy
32 Chronic Obstructive Pulmonary Disease
33 Contraception
34 COVID-19: Acute and Chronic
35 Dermatological Conditions
36 Diabetes Management
37 Gastroesophageal Reflux and Peptic Ulcer Disease
38 Headaches
39 Heart Failure
40 Human Immunodeficiency Virus Disease and Acquired Immunodeficiency Syndrome
41 Menopausal Hormone Therapy
42 Hyperlipidemia
43 Hypertension
44 Hyperthyroidism and Hypothyroidism
45 Obesity
46 Pain Management: Acute and Chronic Pain
47 Pneumonia
48 Sexually Transmitted Diseases and Vaginitis
49 Substance Use Disorder
50 Tuberculosis
51 Upper Respiratory Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa
52 Urinary Tract Infection
Unit IV — Special Drug-Treatment Considerations
Chapter Chapter Title
53 Women as Patients
54 Men as Patients
55 Pediatric Patients
56 Transgender Persons as Patients
57 Geriatric Patients
Exam Overview
Unit Coverage Chapters
I The Foundation 1–10
II Pharmacotherapeutics With Single Drugs 11–27
III Pharmacotherapeutics With Multiple Drugs 28–52
IV Special Drug-Treatment Considerations 53–57
Total Complete Exam Bank 57 Chapters
💊 Unit I — The Foundation
🩺 Chapter 1: The Role of the Nurse Practitioner as Prescriber
Prescribing Accountability Chain
Page 3
, Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition | Complete TestBank
Question 1. ⚖️
Which source provides the primary legal authority defining what an APRN may
prescribe within a particular US jurisdiction?
A. The employer’s medication formulary
B. The APRN’s national certification examination
C. The state nurse practice act and implementing regulations
D. The pharmaceutical manufacturer’s prescribing information
✅ ANS: C
Rationale: State statutes and regulations establish the APRN’s legal scope of
practice and prescriptive authority. National certification demonstrates role and
population-focused competence but does not independently create state
authority. Employers may impose narrower restrictions, but they cannot expand
practice beyond limits established by law.
Why the other options are less appropriate:
• A: An employer formulary controls organizational access, not statutory
authority.
• B: Certification supports licensure but does not replace state law.
• D: Manufacturer information describes medication use, not who may legally
prescribe it.
Prescribing Pearl: Always distinguish legal scope, professional competence,
and employer-granted privileges.
Exam Strategy: When asked who legally defines APRN practice, select the
state legislature or regulatory board.
Question 2. 🗺️
An FNP licensed in State A plans to relocate permanently to State B. Before issuing
the first prescription in State B, which action is most important?
A. Verify State B’s licensure and prescriptive-authority requirements
B. Transfer the existing DEA registration without further review
Page 4
, Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition | Complete TestBank
C. Obtain permission from the former collaborating physician
D. Ask the receiving pharmacy whether it will accept the prescription
✅ ANS: A
Rationale: Prescriptive authority is jurisdiction-specific. The FNP must verify
State B’s licensing, prescribing, collaboration, transition-to-practice, and
controlled-substance requirements. Permission from a previous collaborator or
acceptance by a pharmacy cannot establish legal authority in another state.
Why the other options are less appropriate:
• B: A DEA registration does not replace state authorization.
• C: A former collaborator has no authority in the new jurisdiction.
• D: Pharmacy acceptance does not determine whether a prescription is
legally issued.
Prescribing Pearl: Relocation may change both the extent of authority and the
conditions under which it may be exercised.
Exam Strategy: Confirm legal authorization before considering administrative
matters.
🔗 Prescribing-Authority Block Chain
Question 3. 🔗
Which interpretation of the prescribing-authority chain is correct?
A. Employer privileges automatically create state authority
B. National certification replaces controlled-substance registration
C. DEA registration permits prescribing beyond the APRN’s population focus
D. Each applicable layer must be satisfied before the prescription is issued
✅ ANS: D
Rationale: A lawful prescription may require state authority, active APRN
licensure, controlled-substance authorization, and institutional privileges. Meeting
Page 5
, Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition | Complete TestBank
one requirement does not replace the others. The prescription must also remain
within the APRN’s role, population focus, competence, and professional standard
of care.
Why the other options are less appropriate:
• A: An employer cannot create statutory authority.
• B: Certification and controlled-substance registration serve different
purposes.
• C: DEA registration does not expand clinical scope or population
preparation.
Prescribing Pearl: A DEA number operates only within the authority already
granted by state law.
Exam Strategy: Reject answers suggesting that one credential replaces every
other requirement.
Question 4. 📚
Which description best captures evidence-based prescribing?
A. Following the newest guideline regardless of individual circumstances
B. Integrating research evidence, clinical expertise, and patient preferences
C. Selecting the medication most frequently prescribed by nearby clinicians
D. Using a familiar medication before establishing a treatment goal
✅ ANS: B
Rationale: Evidence-based prescribing combines high-quality research,
professional clinical judgment, and the patient’s goals, risks, values, and
circumstances. Guidelines inform treatment but do not replace individualized
assessment. Every medication should also have a defined therapeutic objective.
Why the other options are less appropriate:
• A: Guidelines should be individualized rather than followed mechanically.
• C: Popularity is not equivalent to evidence.
• D: Familiarity should not replace diagnosis and treatment planning.
Prescribing Pearl: Guidelines support clinical judgment; they do not replace it.
Exam Strategy: Select the option combining evidence, expertise, and patient-
centered care.
Page 6
, Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition | Complete TestBank
Question 5. 🔐
A state permits an NP to prescribe noncontrolled medications but does not
authorize the NP to prescribe controlled substances. The NP subsequently obtains
a DEA registration. What is the correct conclusion?
A. The NP may prescribe Schedule III–V drugs but not Schedule II drugs
B. The DEA registration does not expand the NP’s state-granted authority
C. Controlled drugs may be prescribed when a pharmacist approves them
D. Controlled drugs may be prescribed only through telehealth
✅ ANS: B
Rationale: Federal DEA registration does not override restrictions imposed by
state law. The clinician must first possess state authority to handle controlled
substances and then satisfy applicable federal requirements. A DEA registration
supplements rather than creates state prescriptive authority.
Why the other options are less appropriate:
• A: The state has not authorized any controlled-substance prescribing.
• C: A pharmacist cannot grant prescriptive authority.
• D: Telehealth does not eliminate state or federal requirements.
Prescribing Pearl: State authority forms the legal foundation; DEA registration
is an additional federal requirement.
Exam Strategy: When state and federal laws interact, the prescriber must
satisfy both.
Question 6. 🔬
Dysuria is reported during an urgent-care encounter, but no history, examination,
urinalysis, allergy assessment, or pregnancy screening has been completed.
Which action best reflects sound prescribing practice?
A. Begin a broad-spectrum antibiotic immediately
B. Ask which antibiotic worked during the previous infection
C. Obtain sufficient diagnostic and safety information before prescribing
D. Issue a delayed prescription without documenting an assessment
✅ ANS: C
Rationale: Rational prescribing begins with an adequate assessment and a
defensible working diagnosis. Allergy history, pregnancy possibility, renal function,
Page 7
, Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition | Complete TestBank
illness severity, and local resistance patterns may change treatment. Urgency does
not justify an unsupported prescription when timely assessment is available.
Why the other options are less appropriate:
• A: Broad therapy may be unnecessary or inappropriate.
• B: Previous response does not establish the current diagnosis.
• D: A delayed prescription does not correct the inadequate assessment.
Prescribing Pearl: Prescribing is the result of diagnostic reasoning—not a
substitute for it.
Exam Strategy: When essential diagnostic information is missing, assess
before prescribing.
Question 7. 🛡️
An APRN discovers that a medication dose was calculated using an outdated
weight. The medication has not yet been administered. What is the best
immediate response?
A. Stop the order, correct it, notify the appropriate parties, and document the
event
B. Delete the original order so the error is no longer visible
C. Wait to determine whether the pharmacy detects the problem
D. Leave the order unchanged because the medication was not administered
✅ ANS: A
Rationale: A near miss requires prompt correction and transparent
communication through the appropriate clinical and safety systems. Accurate
documentation supports accountability, continuity, and system improvement. The
absence of patient harm does not eliminate the need to remove the unsafe order.
Why the other options are less appropriate:
• B: Deletion compromises the integrity of the medical record.
• C: Waiting delays correction and transfers responsibility.
• D: The active order continues to create a serious safety risk.
Prescribing Pearl: Near misses identify vulnerabilities before actual patient
harm occurs.
Page 8
, Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition | Complete TestBank
Exam Strategy: Medication-error answers should include immediate safety,
correction, documentation, and prevention.
Four Boundaries of APRN Prescribing
Icon Boundary Essential question
Legal scope Does state law authorize the activity?
Role and population focus Was the APRN educated and certified for this population?
Individual competence Does the APRN possess current knowledge and skill?
Credentialing and privileging Has the healthcare organization authorized the activity?
Question 8. 🏥
A hospital-employed FNP is legally permitted by the state to prescribe a specialty
biologic but has not received the hospital privilege required to initiate the
therapy. What should the FNP do?
A. Prescribe because state authority overrides hospital policy
B. Ask a pharmaceutical representative to approve treatment
C. Initiate treatment and apply for privileges retrospectively
D. Complete the credentialing process before independently initiating therapy
✅ ANS: D
Rationale: State law establishes the outer legal boundary of practice, but an
institution may require special credentialing and privileges for high-risk therapies.
The FNP must comply with lawful organizational requirements. Retrospective
approval does not eliminate the risk created by acting without authorization.
Why the other options are less appropriate:
• A: Legal scope does not automatically establish institutional privileges.
• B: A commercial representative has no credentialing authority.
• C: Privileges must be obtained before independently performing the activity.
Prescribing Pearl: Employer privileges may be narrower—but never broader—
than state scope.
Exam Strategy: Distinguish “legally permitted” from “institutionally
authorized.”
Question 9. 👥
An adult-gerontology primary care NP is asked to independently treat a 10-year-
old child’s newly diagnosed asthma because the clinic is short staffed. Which
response is most appropriate?
Page 9
, Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition | Complete TestBank
A. Prescribe because asthma medications are used across age groups
B. Treat the child if a physician signs the prescription later
C. Arrange care with a pediatric-qualified clinician and provide emergency
stabilization if required
D. Treat because organizational need temporarily expands the NP’s population
focus
✅ ANS: C
Rationale: APRN practice must remain consistent with the role and population
focus for which the clinician was educated, certified, and licensed. Staffing
shortages do not expand population preparation. Emergency stabilization may be
necessary, but continuing pediatric management belongs with an appropriately
qualified clinician.
Why the other options are less appropriate:
• A: Drug familiarity does not establish pediatric competence.
• B: A later signature does not correct a scope mismatch.
• D: Organizational need cannot redefine population-focused preparation.
Prescribing Pearl: Knowing a drug does not establish competence to manage
every population receiving it.
Exam Strategy: Protect population-focus boundaries when they conflict with
convenience.
🤝 Shared Decision-Making Sketch
Page 10
prescribers 6th edition
, Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition | Complete TestBank
Table of Contents
Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th
Edition
Unit I — The Foundation
Chapter Chapter Title
1 The Role of the Nurse Practitioner as Prescriber
2 Review of Basic Principles of Pharmacology
3 Rational Drug Selection
4 Legal and Professional Issues in Prescribing
5 Adverse Drug Reactions
6 An Introduction to Pharmacogenetics and Pharmacogenomics
7 Nutrition and Nutraceuticals
8 Herbal Therapies
9 Cannabis
10 Pharmacoeconomics
Unit II — Pharmacotherapeutics With Single Drugs
Chapter Chapter Title
11 Drugs Affecting the Autonomic Nervous System
12 Drugs Affecting the Central Nervous System
13 Drugs Affecting the Cardiovascular and Renal Systems
14 Drugs Affecting the Respiratory System
15 Drugs Affecting the Hematological System
16 Drugs Affecting the Immune System: Immunizations
17 Drugs Affecting the Immune System: Immunomodulators
18 Drugs Affecting the Gastrointestinal System
19 Pancreatic Hormones and Antidiabetic Drugs
20 Pituitary, Thyroid, and Adrenal Drugs
21 Drugs Affecting the Reproductive System
22 Drugs Affecting the Bones and Joints
23 Drugs Affecting the Integumentary System
24 Drugs Used to Treat Bacterial Infections
25 Drugs Used to Treat Viral, Fungal, and Protozoal Infections
26 Drugs Used to Treat Inflammatory Processes
27 Drugs Used to Treat Eye and Ear Disorders
Unit III — Pharmacotherapeutics With Multiple Drugs
Chapter Chapter Title
28 Anemia
29 Anxiety and Depression
30 Attention-Deficit/Hyperactivity Disorder
Page 2
, Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition | Complete TestBank
Chapter Chapter Title
31 Asthma and Allergy
32 Chronic Obstructive Pulmonary Disease
33 Contraception
34 COVID-19: Acute and Chronic
35 Dermatological Conditions
36 Diabetes Management
37 Gastroesophageal Reflux and Peptic Ulcer Disease
38 Headaches
39 Heart Failure
40 Human Immunodeficiency Virus Disease and Acquired Immunodeficiency Syndrome
41 Menopausal Hormone Therapy
42 Hyperlipidemia
43 Hypertension
44 Hyperthyroidism and Hypothyroidism
45 Obesity
46 Pain Management: Acute and Chronic Pain
47 Pneumonia
48 Sexually Transmitted Diseases and Vaginitis
49 Substance Use Disorder
50 Tuberculosis
51 Upper Respiratory Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa
52 Urinary Tract Infection
Unit IV — Special Drug-Treatment Considerations
Chapter Chapter Title
53 Women as Patients
54 Men as Patients
55 Pediatric Patients
56 Transgender Persons as Patients
57 Geriatric Patients
Exam Overview
Unit Coverage Chapters
I The Foundation 1–10
II Pharmacotherapeutics With Single Drugs 11–27
III Pharmacotherapeutics With Multiple Drugs 28–52
IV Special Drug-Treatment Considerations 53–57
Total Complete Exam Bank 57 Chapters
💊 Unit I — The Foundation
🩺 Chapter 1: The Role of the Nurse Practitioner as Prescriber
Prescribing Accountability Chain
Page 3
, Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition | Complete TestBank
Question 1. ⚖️
Which source provides the primary legal authority defining what an APRN may
prescribe within a particular US jurisdiction?
A. The employer’s medication formulary
B. The APRN’s national certification examination
C. The state nurse practice act and implementing regulations
D. The pharmaceutical manufacturer’s prescribing information
✅ ANS: C
Rationale: State statutes and regulations establish the APRN’s legal scope of
practice and prescriptive authority. National certification demonstrates role and
population-focused competence but does not independently create state
authority. Employers may impose narrower restrictions, but they cannot expand
practice beyond limits established by law.
Why the other options are less appropriate:
• A: An employer formulary controls organizational access, not statutory
authority.
• B: Certification supports licensure but does not replace state law.
• D: Manufacturer information describes medication use, not who may legally
prescribe it.
Prescribing Pearl: Always distinguish legal scope, professional competence,
and employer-granted privileges.
Exam Strategy: When asked who legally defines APRN practice, select the
state legislature or regulatory board.
Question 2. 🗺️
An FNP licensed in State A plans to relocate permanently to State B. Before issuing
the first prescription in State B, which action is most important?
A. Verify State B’s licensure and prescriptive-authority requirements
B. Transfer the existing DEA registration without further review
Page 4
, Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition | Complete TestBank
C. Obtain permission from the former collaborating physician
D. Ask the receiving pharmacy whether it will accept the prescription
✅ ANS: A
Rationale: Prescriptive authority is jurisdiction-specific. The FNP must verify
State B’s licensing, prescribing, collaboration, transition-to-practice, and
controlled-substance requirements. Permission from a previous collaborator or
acceptance by a pharmacy cannot establish legal authority in another state.
Why the other options are less appropriate:
• B: A DEA registration does not replace state authorization.
• C: A former collaborator has no authority in the new jurisdiction.
• D: Pharmacy acceptance does not determine whether a prescription is
legally issued.
Prescribing Pearl: Relocation may change both the extent of authority and the
conditions under which it may be exercised.
Exam Strategy: Confirm legal authorization before considering administrative
matters.
🔗 Prescribing-Authority Block Chain
Question 3. 🔗
Which interpretation of the prescribing-authority chain is correct?
A. Employer privileges automatically create state authority
B. National certification replaces controlled-substance registration
C. DEA registration permits prescribing beyond the APRN’s population focus
D. Each applicable layer must be satisfied before the prescription is issued
✅ ANS: D
Rationale: A lawful prescription may require state authority, active APRN
licensure, controlled-substance authorization, and institutional privileges. Meeting
Page 5
, Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition | Complete TestBank
one requirement does not replace the others. The prescription must also remain
within the APRN’s role, population focus, competence, and professional standard
of care.
Why the other options are less appropriate:
• A: An employer cannot create statutory authority.
• B: Certification and controlled-substance registration serve different
purposes.
• C: DEA registration does not expand clinical scope or population
preparation.
Prescribing Pearl: A DEA number operates only within the authority already
granted by state law.
Exam Strategy: Reject answers suggesting that one credential replaces every
other requirement.
Question 4. 📚
Which description best captures evidence-based prescribing?
A. Following the newest guideline regardless of individual circumstances
B. Integrating research evidence, clinical expertise, and patient preferences
C. Selecting the medication most frequently prescribed by nearby clinicians
D. Using a familiar medication before establishing a treatment goal
✅ ANS: B
Rationale: Evidence-based prescribing combines high-quality research,
professional clinical judgment, and the patient’s goals, risks, values, and
circumstances. Guidelines inform treatment but do not replace individualized
assessment. Every medication should also have a defined therapeutic objective.
Why the other options are less appropriate:
• A: Guidelines should be individualized rather than followed mechanically.
• C: Popularity is not equivalent to evidence.
• D: Familiarity should not replace diagnosis and treatment planning.
Prescribing Pearl: Guidelines support clinical judgment; they do not replace it.
Exam Strategy: Select the option combining evidence, expertise, and patient-
centered care.
Page 6
, Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition | Complete TestBank
Question 5. 🔐
A state permits an NP to prescribe noncontrolled medications but does not
authorize the NP to prescribe controlled substances. The NP subsequently obtains
a DEA registration. What is the correct conclusion?
A. The NP may prescribe Schedule III–V drugs but not Schedule II drugs
B. The DEA registration does not expand the NP’s state-granted authority
C. Controlled drugs may be prescribed when a pharmacist approves them
D. Controlled drugs may be prescribed only through telehealth
✅ ANS: B
Rationale: Federal DEA registration does not override restrictions imposed by
state law. The clinician must first possess state authority to handle controlled
substances and then satisfy applicable federal requirements. A DEA registration
supplements rather than creates state prescriptive authority.
Why the other options are less appropriate:
• A: The state has not authorized any controlled-substance prescribing.
• C: A pharmacist cannot grant prescriptive authority.
• D: Telehealth does not eliminate state or federal requirements.
Prescribing Pearl: State authority forms the legal foundation; DEA registration
is an additional federal requirement.
Exam Strategy: When state and federal laws interact, the prescriber must
satisfy both.
Question 6. 🔬
Dysuria is reported during an urgent-care encounter, but no history, examination,
urinalysis, allergy assessment, or pregnancy screening has been completed.
Which action best reflects sound prescribing practice?
A. Begin a broad-spectrum antibiotic immediately
B. Ask which antibiotic worked during the previous infection
C. Obtain sufficient diagnostic and safety information before prescribing
D. Issue a delayed prescription without documenting an assessment
✅ ANS: C
Rationale: Rational prescribing begins with an adequate assessment and a
defensible working diagnosis. Allergy history, pregnancy possibility, renal function,
Page 7
, Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition | Complete TestBank
illness severity, and local resistance patterns may change treatment. Urgency does
not justify an unsupported prescription when timely assessment is available.
Why the other options are less appropriate:
• A: Broad therapy may be unnecessary or inappropriate.
• B: Previous response does not establish the current diagnosis.
• D: A delayed prescription does not correct the inadequate assessment.
Prescribing Pearl: Prescribing is the result of diagnostic reasoning—not a
substitute for it.
Exam Strategy: When essential diagnostic information is missing, assess
before prescribing.
Question 7. 🛡️
An APRN discovers that a medication dose was calculated using an outdated
weight. The medication has not yet been administered. What is the best
immediate response?
A. Stop the order, correct it, notify the appropriate parties, and document the
event
B. Delete the original order so the error is no longer visible
C. Wait to determine whether the pharmacy detects the problem
D. Leave the order unchanged because the medication was not administered
✅ ANS: A
Rationale: A near miss requires prompt correction and transparent
communication through the appropriate clinical and safety systems. Accurate
documentation supports accountability, continuity, and system improvement. The
absence of patient harm does not eliminate the need to remove the unsafe order.
Why the other options are less appropriate:
• B: Deletion compromises the integrity of the medical record.
• C: Waiting delays correction and transfers responsibility.
• D: The active order continues to create a serious safety risk.
Prescribing Pearl: Near misses identify vulnerabilities before actual patient
harm occurs.
Page 8
, Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition | Complete TestBank
Exam Strategy: Medication-error answers should include immediate safety,
correction, documentation, and prevention.
Four Boundaries of APRN Prescribing
Icon Boundary Essential question
Legal scope Does state law authorize the activity?
Role and population focus Was the APRN educated and certified for this population?
Individual competence Does the APRN possess current knowledge and skill?
Credentialing and privileging Has the healthcare organization authorized the activity?
Question 8. 🏥
A hospital-employed FNP is legally permitted by the state to prescribe a specialty
biologic but has not received the hospital privilege required to initiate the
therapy. What should the FNP do?
A. Prescribe because state authority overrides hospital policy
B. Ask a pharmaceutical representative to approve treatment
C. Initiate treatment and apply for privileges retrospectively
D. Complete the credentialing process before independently initiating therapy
✅ ANS: D
Rationale: State law establishes the outer legal boundary of practice, but an
institution may require special credentialing and privileges for high-risk therapies.
The FNP must comply with lawful organizational requirements. Retrospective
approval does not eliminate the risk created by acting without authorization.
Why the other options are less appropriate:
• A: Legal scope does not automatically establish institutional privileges.
• B: A commercial representative has no credentialing authority.
• C: Privileges must be obtained before independently performing the activity.
Prescribing Pearl: Employer privileges may be narrower—but never broader—
than state scope.
Exam Strategy: Distinguish “legally permitted” from “institutionally
authorized.”
Question 9. 👥
An adult-gerontology primary care NP is asked to independently treat a 10-year-
old child’s newly diagnosed asthma because the clinic is short staffed. Which
response is most appropriate?
Page 9
, Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition | Complete TestBank
A. Prescribe because asthma medications are used across age groups
B. Treat the child if a physician signs the prescription later
C. Arrange care with a pediatric-qualified clinician and provide emergency
stabilization if required
D. Treat because organizational need temporarily expands the NP’s population
focus
✅ ANS: C
Rationale: APRN practice must remain consistent with the role and population
focus for which the clinician was educated, certified, and licensed. Staffing
shortages do not expand population preparation. Emergency stabilization may be
necessary, but continuing pediatric management belongs with an appropriately
qualified clinician.
Why the other options are less appropriate:
• A: Drug familiarity does not establish pediatric competence.
• B: A later signature does not correct a scope mismatch.
• D: Organizational need cannot redefine population-focused preparation.
Prescribing Pearl: Knowing a drug does not establish competence to manage
every population receiving it.
Exam Strategy: Protect population-focus boundaries when they conflict with
convenience.
🤝 Shared Decision-Making Sketch
Page 10
